» Articles » PMID: 6134149

Anaphylactic Reactions to Repeated Intravesical Instillation with Cisplatin

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1983 Jun 18
PMID 6134149
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hyperthermia Improves Solubility of Intravesical Chemotherapeutic Agents.

Grimberg D, Shah A, Tan W, Etienne W, Spasojevic I, Inman B Bladder Cancer. 2022; 6(4):461-470.

PMID: 36118287 PMC: 9441059. DOI: 10.3233/BLC-200350.


Application of nanotechnology in the diagnosis and treatment of bladder cancer.

Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T J Nanobiotechnology. 2021; 19(1):393.

PMID: 34838048 PMC: 8626998. DOI: 10.1186/s12951-021-01104-y.


Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.

Kates M, Date A, Yoshida T, Afzal U, Kanvinde P, Babu T Clin Cancer Res. 2017; 23(21):6592-6601.

PMID: 28808039 PMC: 6487844. DOI: 10.1158/1078-0432.CCR-17-1082.


Prevention and management of antineoplastic-induced hypersensitivity reactions.

Zanotti K, Markman M Drug Saf. 2001; 24(10):767-79.

PMID: 11676304 DOI: 10.2165/00002018-200124100-00005.


Hypersensitivity and cross-reactivity to cisplatin and analogues.

Shlebak A, Clark P, Green J Cancer Chemother Pharmacol. 1995; 35(4):349-51.

PMID: 7828281 DOI: 10.1007/BF00689458.